Literature DB >> 32304142

Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model.

Aline de Conti1, Volodymyr Tryndyak1, Rose A Willett1, Barbara Borowa-Mazgaj1, Anna Watson1, Ralph Patton2, Sangeeta Khare3, Levan Muskhelishvili2, Greg R Olson2, Mark I Avigan4, Carl E Cerniglia3, Sharon A Ross5, Arun J Sanyal6, Frederick A Beland1, Ivan Rusyn7, Igor P Pogribny1.   

Abstract

Interindividual variability and sexual dimorphisms in the development of nonalcoholic fatty liver disease (NAFLD) are still poorly understood. In the present study, male and female strains of Collaborative Cross (CC) mice were fed a high-fat and high-sucrose (HF/HS) diet or a control diet for 12 weeks to investigate interindividual- and sex-specific variations in the development of NAFLD. The severity of liver steatosis varied between sexes and individual strains and was accompanied by an elevation of serum markers of insulin resistance, including increases in total cholesterol, low-density lipoproteins, high-density lipoproteins, phospholipids, and glucose. The development of NAFLD was associated with overexpression of the critical fatty acid uptake and de novo lipogenesis genes Pparg, Mogat1, Cd36, Acaab1, Fabp2, and Gdf15 in male and female mice. The expression of Pparg, Mogat1, and Cd36 was positively correlated with liver triglycerides in male mice, and Mogat1 and Cd36 expression were positively correlated with liver triglycerides in female mice. Our results indicate the value of CC mice in combination with HF/HS diet-induced alterations as an approach to study the susceptibility and interindividual variabilities in the pathogenesis of nonalcoholic fatty liver and early nonalcoholic steatohepatitis at the population level, uncovering of susceptible and resistant cohorts, and identifying sex-specific molecular determinants of disease susceptibility.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  zzm321990Cd36zzm321990; collaborative cross mice; gene expression; nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2020        PMID: 32304142      PMCID: PMC7552439          DOI: 10.1096/fj.202000194R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  59 in total

Review 1.  Preclinical models of non-alcoholic fatty liver disease.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Arun J Sanyal
Journal:  J Hepatol       Date:  2017-11-09       Impact factor: 25.083

Review 2.  Histological Assessment of NAFLD.

Authors:  Pierre Bedossa
Journal:  Dig Dis Sci       Date:  2016-02-13       Impact factor: 3.199

Review 3.  The collaborative cross: a recombinant inbred mouse population for the systems genetic era.

Authors:  David W Threadgill; Darla R Miller; Gary A Churchill; Fernando Pardo-Manuel de Villena
Journal:  ILAR J       Date:  2011

4.  Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.

Authors:  Mitsutaka Inoue; Takaaki Ohtake; Wataru Motomura; Nobuhiko Takahashi; Yayoi Hosoki; Shigeki Miyoshi; Yasuaki Suzuki; Hiroyuki Saito; Yutaka Kohgo; Toshikatsu Okumura
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

5.  Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.

Authors:  Zheng Zheng Li; Michael Berk; Thomas M McIntyre; Ariel E Feldstein
Journal:  J Biol Chem       Date:  2009-01-01       Impact factor: 5.157

Review 6.  Animal models of NAFLD from a hepatologist's point of view.

Authors:  Daniel Jahn; Stefan Kircher; Heike M Hermanns; Andreas Geier
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-07-07       Impact factor: 5.187

7.  Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.

Authors:  Andreas Teufel; Timo Itzel; Wiebke Erhart; Mario Brosch; Xiao Yu Wang; Yong Ook Kim; Witigo von Schönfels; Alexander Herrmann; Stefan Brückner; Felix Stickel; Jean-François Dufour; Triantafyllos Chavakis; Claus Hellerbrand; Rainer Spang; Thorsten Maass; Thomas Becker; Stefan Schreiber; Clemens Schafmayer; Detlef Schuppan; Jochen Hampe
Journal:  Gastroenterology       Date:  2016-06-16       Impact factor: 22.682

8.  Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes.

Authors:  Isabel Graupera; Mar Coll; Elisa Pose; Chiara Elia; Salvatore Piano; Elsa Solà; Delia Blaya; Patricia Huelin; Cristina Solé; Rebeca Moreira; Gloria de Prada; Núria Fabrellas; Adrià Juanola; Manuel Morales-Ruiz; Pau Sancho-Bru; Càndid Villanueva; Pere Ginès
Journal:  Sci Rep       Date:  2017-05-12       Impact factor: 4.379

9.  Non-alcoholic fatty liver and the gut microbiota.

Authors:  Stavros Bashiardes; Hagit Shapiro; Shachar Rozin; Oren Shibolet; Eran Elinav
Journal:  Mol Metab       Date:  2016-06-14       Impact factor: 7.422

Review 10.  Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.

Authors:  David Højland Ipsen; Jens Lykkesfeldt; Pernille Tveden-Nyborg
Journal:  Cell Mol Life Sci       Date:  2018-06-23       Impact factor: 9.261

View more
  3 in total

1.  Rosiglitazone Requires Hepatocyte PPARγ Expression to Promote Steatosis in Male Mice With Diet-Induced Obesity.

Authors:  Samuel M Lee; Jose Muratalla; Alberto Diaz-Ruiz; Pablo Remon-Ruiz; Maximilian McCann; Chong W Liew; Rhonda D Kineman; Jose Cordoba-Chacon
Journal:  Endocrinology       Date:  2021-11-01       Impact factor: 5.051

2.  Genetic background and sex control the outcome of high-fat diet feeding in mice.

Authors:  Alexis Maximilien Bachmann; Jean-David Morel; Gaby El Alam; Sandra Rodríguez-López; Tanes Imamura de Lima; Ludger J E Goeminne; Giorgia Benegiamo; Sylvain Loric; Marc Conti; Maroun Bou Sleiman; Johan Auwerx
Journal:  iScience       Date:  2022-05-25

3.  Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet.

Authors:  Volodymyr P Tryndyak; Rose A Willett; Mark I Avigan; Arun J Sanyal; Frederick A Beland; Ivan Rusyn; Igor P Pogribny
Journal:  Epigenetics       Date:  2022-03-24       Impact factor: 4.861

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.